Vault-13

CALMARE THERAPEUTICS INC

CTTC · CUSIP 13126R102

2 institutional holders
161,550161.6k shares reported held*
$27.0kreported value*

* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.17.

Holders, Q4 2019

#ManagerLocationShares Value% of their portfolioChangeShares change
1 WEYBOSSET RESEARCH & MANAGEMENT LLC 0.01% of their portfolio PROVIDENCE, RI 161,400161.4k $27.0k $27.0k 0.01% —
2 Private Capital Group, LLC 0.00% of their portfolio WEST HARTFORD, CT 150150 $0 $0 0.00% —